Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,535 | -28,466 | -18,944 | -12,491 | -4,768 |
| Depreciation Amortization | 43 | 40 | 16 | 115 | 87 |
| Other Working Capital | -626 | -28 | 2,070 | 329 | -718 |
| Other Operating Activity | 3,784 | 3,158 | 2,785 | 2,283 | 447 |
| Operating Cash Flow | $-29,334 | $-25,296 | $-14,073 | $-9,764 | $-4,952 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -63 | -30 | -15 | -7 |
| Other Investing Activity | 0 | 0 | 0 | -320 | -364 |
| Investing Cash Flow | $0 | $-63 | $-30 | $-335 | $-371 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 147 | 76,954 | 33,750 | 11,707 | 6,394 |
| Financing Cash Flow | $147 | $76,954 | $33,750 | $11,707 | $6,394 |
| Beginning Cash Position | 75,807 | 24,212 | 4,565 | 2,957 | 1,886 |
| End Cash Position | 46,620 | 75,807 | 24,212 | 4,565 | 2,957 |
| Net Cash Flow | $-29,187 | $51,595 | $19,647 | $1,608 | $1,071 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,334 | -25,296 | -14,073 | -9,764 | -4,952 |
| Capital Expenditure | 0 | -63 | -30 | -15 | -7 |
| Free Cash Flow | -29,334 | -25,359 | -14,103 | -9,779 | -4,959 |